Health
Research reveals underperformance of many Phase III oncology trials – News-Medical.Net
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than…
New research in the September 2021 issue of JNCCN-;Journal of the National Comprehensive Cancer Network finds that more than 80% of therapies tested in Phase III oncology trials did not achieve meaningful clinical benefit in prolonging survival. The researchers…
Continue Reading
-
General19 hours agoNew York Marathon won by Benson Kipruto wins in classic photo finish, Eliud Kipchoge announces final tour
-
Noosa News15 hours agoWhat led to the giant, damaging hail which smashed parts of Queensland over the weekend?
-
General21 hours agoAustralia’s Kimberly Birrell loses Chennai Open final but earns sportsmanship award
-
Noosa News20 hours agoConcrete Playground’s Editors on What’s Trending After Dark